Pharmacogenomics of medications given via nonconventional administration routes: a scoping review - Supplementary Information

Table S1: Characteristics of included pharmacogenomics studies involving intramuscular administration routes 

Table S2: Outcomes and results of included pharmacogenomics studies on intramuscular administration routes

Table S3: Characteristics of included pharmacogenomic studies on intrathecal/intraventricular administration routes

Table S4: Outcomes and results of included pharmacogenomics studies on intrathecal/intraventricular administration routes

Table S5: Characteristics of included pharmacogenomics studies on intrahepatic arterial, intratympanic, and subcutaneous administration routes

Table S6: Outcomes and results of included pharmacogenomics studies on intrahepatic arterial, intratympanic, and subcutaneous administration routes

Table S7: Characteristics of included pharmacogenomics studies on topical/intralesional and transdermal administration routes

Table S8: Outcomes and results of included pharmacogenomics studies on topical/intralesional administration routes

Table S9: Outcomes and results of included pharmacogenomics studies on transdermal administration routes

Table S10: Recommendations for Medications Given via a Non-Conventional Administration Route Provided by Pharmacogenomic Associations